Regeneron Pharmaceuticals is seeing revenue growth in key products that is now offsetting declining revenue in its previous ...

Researchers have discovered a promising new approach to lung cancer treatment. A small molecule called AVJ16 selectively blocks the cancer-driving protein IGF2BP1, halting tumor growth in preclinical ...

Cancer knows no bounds when it comes to who is afflicted with the illness. These celebrity chefs found themselves staring ...

Despite flat overall Q2 2025 sales, Keytruda's continued strong performance in oncology supports long-term bullish prospects ...

The Trump administration may take a stake in Lithium Americas, Syensqo reopens a synthetic vanillin plant, Genmab inks $8 ...

Genmab has entered into a definitive agreement to acquire Merus in an all-cash transaction for a total consideration of USD 8.0 billion, making it one of ...

They called their effort the Funkcancer Foundation — a nod to the fundraising initiative that supported the Funkhouser family ...

MILLIONS of Brits who pop pills for heartburn could be at greater risk of a deadly tummy bug, experts warn. The drugs, called ...

Study will evaluate ELI-002 7P in combination with chemotherapy and a checkpoint inhibitor (“CPI”) in the neoadjuvant settingTrial is anticipated ...

In 2025, there will be a complicated combination of opportunities and difficulties in the healthcare innovation landscape, ...

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced the appointment of Alan Sandler, ...